Reclassification of marijuana from a Schedule I to a Schedule III drug in the US may be on the horizon, with President Biden endorsing the reclassification of marijuana as a less dangerous drug in May.Tilray CEO Irwin Simon joins Wealth! with Yahoo Finance Anchor Julie Hyman to discuss the potential for the US to reschedule marijuana on the federal level and how future … [Read more...] about What the US can gain from rescheduling marijuana: Tilray CEO
Tilray
Tilray, Inc. a ‘failing cannabis player,’ claims short-seller Kerrisdale Capital
Kerrisdale Capital said it is short Tilray, Inc. (NASDAQ:TLRY) in a report Monday, describing the company as a "failing cannabis player." The short-seller added that the company is running a "familiar playbook for unsuccessful businesses trading in the public markets." Tilray shares are down more than 6% following the report, trading around the $2.75 per share mark. However, … [Read more...] about Tilray, Inc. a ‘failing cannabis player,’ claims short-seller Kerrisdale Capital
Can Tilray successfully synergize its cannabis, alcohol businesses?
With its right hand, Tilray Brands has consolidated a swath of the Canadian cannabis market, most recently buying Hexo Corp. in its quest to grow market share. With its left hand, Tilray has gone on a beverage alcohol acquisition bender in the United States. After several alcohol acquisitions that turned Tilray into one of the largest U.S. craft brewers, the company recently … [Read more...] about Can Tilray successfully synergize its cannabis, alcohol businesses?
